[Surgical treatment of Siewert II adenocarcinoma of the esophagogastric junction].
Zhonghua Wei Chang Wai Ke Za Zhi
; 15(9): 910-2, 2012 Sep.
Article
em Zh
| MEDLINE
| ID: mdl-22990921
ABSTRACT
OBJECTIVE:
To explore the outcomes after surgical treatment of esophagogastric junction carcinoma (EGJC).METHODS:
One hundred and eighty-five patients with EGJC undergoing surgery from October 2000 to September 2006 at the Cancer Hospital of Shantou University were reviewed retrospectively. The clinical outcomes were compared between transthoracic and transabdominal approach.RESULTS:
Of the 185 patients, 133 underwent operation via transthoracic approach and 52 via transabdominal approach. The postoperative complication rates were 10.5%(14/133) and 11.5%(6/52) and the 1-, 3-, 5-year overall survival rates were 83.9%, 44.5%, 32.9% and 86.0%, 38.0%, 30.0% in transthoracic and transabdominal groups respectively, and the difference were not statistically significant (both P>0.05).CONCLUSION:
Surgical approach should be individualized for EGCJ.
Buscar no Google
Bases de dados:
MEDLINE
Assunto principal:
Adenocarcinoma
/
Junção Esofagogástrica
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
Zh
Revista:
Zhonghua Wei Chang Wai Ke Za Zhi
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2012
Tipo de documento:
Article
País de afiliação:
China